Skip to content
DraconiticResearch
Search Sources API
210,089 studies31 sourcesUpdated 7 min ago
Peer-reviewedCC BY 4.0BMC Cardiovascular Disorders

Evaluation of the relationship between cardiac remodeling and serum FABP3 in hypertensive patients

  • Meltem Uyaner Kan1
  • Hasan Kan2
  • Sefa Tatar3
  1. 1Department of Medical Biochemistry, Niğde Omer Halisdemir University Training and Research Hospital, Niğde, Türkiye
  2. 2Department of Cardiology, Niğde Omer Halisdemir University Training and Research Hospital, Niğde, Türkiye
  3. 3Department of Cardiology, Necmettin Erbakan University, Konya, Türkiye
Read full textDOICite

Abstract

Background: Hypertension is a leading cause of cardiovascular disease and all-cause mortality. In addition, owing to the pathological processes it causes in the vascular bed, it leads to end-organ damage, thereby contributing to morbidity. FABP3 (fatty acid binding protein 3) is a protein primarily expressed in the cardiac muscle, skeletal muscle, and kidney, and plays an important role in cardiomyocyte homeostasis.

Methods: Echocardiographic evaluation was performed in 41 normotensive controls and 120 patients with hypertension. Patients with cardiac remodelling (n = 50) and hypertrophy (n = 33) were identified by calculating the left ventricular mass and relative wall thickness. FABP3 levels were measured in serum samples using ELISA.

Results: FABP3 levels demonstrated an increasing trend (p < 0.0001) across the control, non-remodelled hypertensive, remodelling, and hypertrophy groups (1.27 ± 0.81, 1.85 ± 0.75, 2.31 ± 1.06, and 2.85 ± 1.71 ng/ml, respectively). FABP3 levels were significantly but weakly correlated with posterior wall thickness (ρ = 0.29), relative wall thickness (ρ = 0.23), and troponin levels (ρ = 0.2).

Conclusion: These findings suggest that FABP3 may be associated with hypertension-mediated cardiac remodelling and left ventricular hypertrophy. FABP3 may have potential as a supportive biomarker reflecting subclinical cardiac involvement in patients with hypertension.

Related

  1. Automatic transesophageal echocardiographic evaluation of patients with mitral valve prolapse: comparison with patients without structural cardiac chamber remodeling (an exploratory study)
    Marcelo Luiz Campos Vieira, Ana C. T. Rodrigues, Edgar Daminello +17
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Prevalence and associated factors of chronic kidney disease among hypertensive patients attending cardiac clinic at a tertiary hospital in Tanzania: a hospital-based cross-sectional study
    Jamila A Mwinyimvua, Benedicto T Mgala, Jacqueline G Shoo +2
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textGeneral medicineCrossref
  3. Evaluation of Alysis-001 cuffless blood pressure estimation algorithm against the European Society of Hypertension awake/asleep test criteria in hypertensive patients
    Kazuhiro Hongyo, Atsushi Hirayama, Kosuke Shimizu +8
    Hypertension ResearchPeer-reviewedCC BY 4.0Full textCardiovascular medicinePMC
  4. Temporal trends in bystander cardiopulmonary resuscitation and favourable neurological outcome among older patients with out-of-hospital cardiac arrest stratified by bystander-patient relationship and age: a JCS-ReSS study.
    Akira Funada, Yoshikazu Goto, Masayuki Takamura +3
    Resuscitation plusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Magnetic resonance imaging evaluation of myocardial and hepatic tissue remodeling and cardiac function in sickle cell anemia
    Serhat Başaran, Kaan Esen, Aydan Akdeniz +2
    Diagnostic and Interventional RadiologyPeer-reviewedCC BY-NC 4.0Full textHuman geneticsPMC

Cite

BibTeXRIS
BibTeX
@article{kan2026evaluation,
  title = {{Evaluation of the relationship between cardiac remodeling and serum FABP3 in hypertensive patients}},
  author = {Meltem Uyaner Kan and Hasan Kan and Sefa Tatar},
  journal = {BMC Cardiovascular Disorders},
  year = {2026},
  month = aug,
  doi = {10.1186/s12872-026-06439-8},
  url = {https://doi.org/10.1186/s12872-026-06439-8},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Evaluation of the relationship between cardiac remodeling and serum FABP3 in hypertensive patients
AU  - Meltem Uyaner Kan
AU  - Hasan Kan
AU  - Sefa Tatar
PY  - 2026
DA  - 2026/08/08
JO  - BMC Cardiovascular Disorders
DO  - 10.1186/s12872-026-06439-8
UR  - https://doi.org/10.1186/s12872-026-06439-8
AB  - Background: Hypertension is a leading cause of cardiovascular disease and all-cause mortality. In addition, owing to the pathological processes it causes in the vascular bed, it leads to end-organ damage, thereby contributing to morbidity. FABP3 (fatty acid binding protein 3) is a protein primarily expressed in the cardiac muscle, skeletal muscle, and kidney, and plays an important role in cardiomyocyte homeostasis.  Methods: Echocardiographic evaluation was performed in 41 normotensive controls and 120 patients with hypertension. Patients with cardiac remodelling (n = 50) and hypertrophy (n = 33) were identified by calculating the left ventricular mass and relative wall thickness. FABP3 levels were measured in serum samples using ELISA.  Results: FABP3 levels demonstrated an increasing trend (p < 0.0001) across the control, non-remodelled hypertensive, remodelling, and hypertrophy groups (1.27 ± 0.81, 1.85 ± 0.75, 2.31 ± 1.06, and 2.85 ± 1.71 ng/ml, respectively). FABP3 levels were significantly but weakly correlated with posterior wall thickness (ρ = 0.29), relative wall thickness (ρ = 0.23), and troponin levels (ρ = 0.2).  Conclusion: These findings suggest that FABP3 may be associated with hypertension-mediated cardiac remodelling and left ventricular hypertrophy. FABP3 may have potential as a supportive biomarker reflecting subclinical cardiac involvement in patients with hypertension.
SN  - 1471-2261
ER  -